Saturday 17 October 2026
Export NVST’s income statement to Excel — free account
Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024. In the quarter to June 2026, revenue grew 7.10%, EPS grew 106.3%, free cash flow grew 37.6% and total debt was flat, each against the same quarter a year earlier.
22.90
0.60
−2.55%
Follow NVST
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 7 | 8 |
+8 more TTM periods Free account |
| 3.06% | 2.21% | 1.56% | 0.50% | ||
| 1.69% | 1.23% | 0.85% | 0.27% | ||
ROIC |
5.05% | 4.36% | 4.04% | 3.47% | |
Return on Tangible Assets |
6.57% | 4.73% | 3.20% | 1.08% | |
Average Days of Receivables |
55.83 | 56.75 | 57.66 | 56.51 | |
Free Cash Flow per Share |
1.54 | 1.34 | 1.37 | 1.58 | |
Free Cash Flow |
249.00 | 220.30 | 230.90 | 263.10 | |
Capital Expenditures |
(53.60) | (51.80) | (44.80) | (37.00) | |
| Other line items | |||||
Cash ROIC |
4.42% | 3.93% | 4.00% | 4.64% | |
Accounts Receivable Turnover |
6.65 | 6.77 | 6.86 | 6.57 | |
Accounts Payable Turnover |
7.06 | 7.60 | 6.73 | 7.15 | |
Inventory Turnover |
4.46 | 4.51 | 4.66 | 4.22 | |
Average Days of Payables |
54.30 | 48.96 | 56.73 | 48.53 | |
Days of Inventory on Hand |
83.04 | 86.49 | 85.30 | 90.47 | |
Tax Rate |
(0.59) | (0.66) | (0.73) | (0.90) | |
Research and Development Expense of Revenue |
4.23% | 4.23% | 4.19% | 4.14% | |
Selling, General and Administrative Expense of Revenue |
41.43% | 42.11% | 42.53% | 43.90% | |
Share Based Compensation of Revenue |
1.42% | 1.45% | 1.38% | 1.39% | |
Interest Coverage |
7.73 | 6.90 | 5.90 | 5.22 | |
Operating CF/Net income |
3.19 | 4.02 | 5.87 | 19.61 | |
Depreciation/Fixed assets |
0.53 | 0.52 | 0.52 | 0.53 | |
Capex/Depreciation |
(0.35) | (0.33) | (0.29) | (0.24) | |
Revenue per Share |
17.64 | 17.13 | 16.19 | 15.78 | |
Operating CF per Share |
1.87 | 1.66 | 1.64 | 1.81 | |
Capex per Share |
(0.33) | (0.32) | (0.27) | (0.22) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 |
Columns are period end dates